Invesco Ltd. Eye Point Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$503 Billion
Q1 2025

A detailed history of Invesco Ltd. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 42,948 shares of EYPT stock, worth $428,191. This represents 0.0% of its overall portfolio holdings.

Number of Shares

42,948

Previous 15,657 174.31%

Holding current value

$428,191

Previous $116,000 100.0%

% of portfolio

0.0%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$5.42 - $9.22 $147,917 - $251,623	27,291 Added 174.31%	42,948 $232,000
Q4 2024 Feb 13, 2025	BUY	$7.02 - $12.12 $15,282 - $26,385	2,177 Added 16.15%	15,657 $116,000
Q3 2024 Nov 12, 2024	SELL	$7.58 - $10.54 $1,644 - $2,287	-217 Reduced 1.58%	13,480 $107,000
Q2 2024 Aug 13, 2024	SELL	$8.16 - $22.89 $1.95 Million - $5.47 Million	-238,896 Reduced 94.58%	13,697 $119,000
Q1 2024 May 14, 2024	SELL	$19.93 - $29.71 $712,696 - $1.06 Million	-35,760 Reduced 12.4%	252,593 $5.22 Million
Q4 2023 Feb 12, 2024	BUY	$5.71 - $24.13 $1.65 Million - $6.96 Million	288,353 New	288,353 $6.66 Million
Q2 2022 Aug 15, 2022	SELL	$7.25 - $12.71 $949,742 - $1.66 Million	-130,999 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.67 - $14.11 $54,933 - $89,400	-6,336 Reduced 4.61%	130,999 $1.59 Million
Q4 2021 Feb 14, 2022	SELL	$10.18 - $18.4 $337,049 - $609,205	-33,109 Reduced 19.43%	137,335 $1.68 Million
Q3 2021 Nov 15, 2021	BUY	$7.51 - $11.72 $1.28 Million - $2 Million	170,444 New	170,444 $1.78 Million

Others Institutions Holding EYPT

# of Institutions

164

Shares Held

71.6M

Call Options Held

232K

Put Options Held

207K

View Full List

About EyePoint Pharmaceuticals, Inc.

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $340M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

More about EYPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account